6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide

C73H78N24O8S7 — CID 160591360

IUPAC6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide
SMILESCc1cnc(NC(=O)CCSc2ccc3c(=O)[nH][nH]c3c2)s1.Cc1cnc(NCCCSc2ccc3c(=O)[nH][nH]c3c2)s1.O=C(CCSc1ccc2c(=O)[nH][nH]c2c1)Nc1cc(C2CC2)[nH]n1.O=C(CCSc1ccc2c(=O)[nH][nH]c2c1)Nc1nccnn1.O=c1[nH][nH]c2cc(SCCCNc3cc(C4CC4)[nH]n3)ccc12
InChIInChI=1S/C16H17N5O2S.C16H19N5OS.C14H14N4O2S2.C14H16N4OS2.C13H12N6O2S/c22-15(17-14-8-12(18-20-14)9-1-2-9)5-6-24-10-3-4-11-13(7-10)19-21-16(11)23;22-16-12-5-4-11(8-14(12)19-21-16)23-7-1-6-17-15-9-13(18-20-15)10-2-3-10;1-8-7-15-14(22-8)16-12(19)4-5-21-9-2-3-10-11(6-9)17-18-13(10)20;1-9-8-16-14(21-9)15-5-2-6-20-10-3-4-11-12(7-10)17-18-13(11)19;20-11(16-13-14-4-5-15-19-13)3-6-22-8-1-2-9-10(7-8)17-18-12(9)21/h3-4,7-9H,1-2,5-6H2,(H2,19,21,23)(H2,17,18,20,22);4-5,8-10H,1-3,6-7H2,(H2,17,18,20)(H2,19,21,22);2-3,6-7H,4-5H2,1H3,(H,15,16,19)(H2,17,18,20);3-4,7-8H,2,5-6H2,1H3,(H,15,16)(H2,17,18,19);1-2,4-5,7H,3,6H2,(H2,17,18,21)(H,14,16,19,20)
InChIKeyRDBIPUKQHRHQAG-UHFFFAOYSA-N
MW1644.06 g/mol
LogP12.75
Rot. Bonds29

About 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide

6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide (PubChem CID 160591360) has the molecular formula C73H78N24O8S7 and a molecular weight of 1644.06 g/mol. Its IUPAC name is 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide.

Molecular Properties

Compound Name6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide
PubChem CID160591360
Molecular FormulaC73H78N24O8S7
Molecular Weight1644.06 g/mol
Exact Mass1642.45
IUPAC Name6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide
SMILESCc1cnc(NC(=O)CCSc2ccc3c(=O)[nH][nH]c3c2)s1.Cc1cnc(NCCCSc2ccc3c(=O)[nH][nH]c3c2)s1.O=C(CCSc1ccc2c(=O)[nH][nH]c2c1)Nc1cc(C2CC2)[nH]n1.O=C(CCSc1ccc2c(=O)[nH][nH]c2c1)Nc1nccnn1.O=c1[nH][nH]c2cc(SCCCNc3cc(C4CC4)[nH]n3)ccc12
InChIInChI=1S/C16H17N5O2S.C16H19N5OS.C14H14N4O2S2.C14H16N4OS2.C13H12N6O2S/c22-15(17-14-8-12(18-20-14)9-1-2-9)5-6-24-10-3-4-11-13(7-10)19-21-16(11)23;22-16-12-5-4-11(8-14(12)19-21-16)23-7-1-6-17-15-9-13(18-20-15)10-2-3-10;1-8-7-15-14(22-8)16-12(19)4-5-21-9-2-3-10-11(6-9)17-18-13(10)20;1-9-8-16-14(21-9)15-5-2-6-20-10-3-4-11-12(7-10)17-18-13(11)19;20-11(16-13-14-4-5-15-19-13)3-6-22-8-1-2-9-10(7-8)17-18-12(9)21/h3-4,7-9H,1-2,5-6H2,(H2,19,21,23)(H2,17,18,20,22);4-5,8-10H,1-3,6-7H2,(H2,17,18,20)(H2,19,21,22);2-3,6-7H,4-5H2,1H3,(H,15,16,19)(H2,17,18,20);3-4,7-8H,2,5-6H2,1H3,(H,15,16)(H2,17,18,19);1-2,4-5,7H,3,6H2,(H2,17,18,21)(H,14,16,19,20)
InChIKeyRDBIPUKQHRHQAG-UHFFFAOYSA-N
XLogP12.75
TPSA476.42 Ų
H-Bond Donors17
H-Bond Acceptors24
Rotatable Bonds29
Heavy Atoms112
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001644.06
LogP ≤ 512.75
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide?
The IUPAC name of 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide (CID 160591360) is 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide.
What is the SMILES notation for 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide?
The canonical SMILES for 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide is Cc1cnc(NC(=O)CCSc2ccc3c(=O)[nH][nH]c3c2)s1.Cc1cnc(NCCCSc2ccc3c(=O)[nH][nH]c3c2)s1.O=C(CCSc1ccc2c(=O)[nH][nH]c2c1)Nc1cc(C2CC2)[nH]n1.O=C(CCSc1ccc2c(=O)[nH][nH]c2c1)Nc1nccnn1.O=c1[nH][nH]c2cc(SCCCNc3cc(C4CC4)[nH]n3)ccc12.
What is the InChIKey of 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide?
The InChIKey is RDBIPUKQHRHQAG-UHFFFAOYSA-N. The full InChI is InChI=1S/C16H17N5O2S.C16H19N5OS.C14H14N4O2S2.C14H16N4OS2.C13H12N6O2S/c22-15(17-14-8-12(18-20-14)9-1-2-9)5-6-24-10-3-4-11-13(7-10)19-21-16(11)23;22-16-12-5-4-11(8-14(12)19-21-16)23-7-1-6-17-15-9-13(18-20-15)10-2-3-10;1-8-7-15-14(22-8)16-12(19)4-5-21-9-2-3-10-11(6-9)17-18-13(10)20;1-9-8-16-14(21-9)15-5-2-6-20-10-3-4-11-12(7-10)17-18-13(11)19;20-11(16-13-14-4-5-15-19-13)3-6-22-8-1-2-9-10(7-8)17-18-12(9)21/h3-4,7-9H,1-2,5-6H2,(H2,19,21,23)(H2,17,18,20,22);4-5,8-10H,1-3,6-7H2,(H2,17,18,20)(H2,19,21,22);2-3,6-7H,4-5H2,1H3,(H,15,16,19)(H2,17,18,20);3-4,7-8H,2,5-6H2,1H3,(H,15,16)(H2,17,18,19);1-2,4-5,7H,3,6H2,(H2,17,18,21)(H,14,16,19,20).
What are the key properties of 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide?
6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide has a molecular weight of 1644.06 g/mol, XLogP of 12.75, 29 rotatable bonds, 17 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 6-[3-[(5-cyclopropyl-1H-pyrazol-3-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-cyclopropyl-1H-pyrazol-3-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;6-[3-[(5-methyl-1,3-thiazol-2-yl)amino]propylsulfanyl]-1,2-dihydroindazol-3-one;N-(5-methyl-1,3-thiazol-2-yl)-3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]propanamide;3-[(3-oxo-1,2-dihydroindazol-6-yl)sulfanyl]-N-(1,2,4-triazin-3-yl)propanamide is sourced from PubChem (CID 160591360), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).